RespirAq Humidifier Usability During Invasive Ventilation

Auckland University of Technology20 enrolled

Overview

This study aims to capture preliminary safety and effectiveness information on a near-final humidifier device design and to provide data for more extensive research, if required. This feasibility study will investigate the following: process, resources, management, and scientific aspects of delivering humidification by the RespirAq humidifier device in ventilated patients.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Mechanical Ventilation

Interventions

RespirAq HumidificationDEVICE

Humidifier

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Patients scheduled for coronary artery bypass surgery (CABG) will be recruited before their surgical procedure at the Waikato district health board during February, March, and April of 2021. Exclusion Criteria: * Age \<18 years * Have any other condition which, at the investigator's discretion, is believed may present a safety risk or impact the feasibility of the study or the study results * Patients admitted for emergency CABG surgery * Unable to provide written informed consent before surgery * Patients who would be contra-indicated to HME humidification devices

Outcomes

Primary Outcomes

Temperature

Meet ISO standard

Time frame: max 24 hours

Humidity

Meet ISO standard

Time frame: max 24 hours

Central Contacts

Catherine Redmond

CONTACT

+649 921 9999 catherine.redmond@aut.ac.nz

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.